How much revenue does Sanofi India make?

Sanofi India reported 19.89 billion INR in revenue for fiscal year 2024, up 0.4% from 19.82 billion INR in fiscal year 2023. In Q2 2025 revenue was 4.06 billion INR.

What companies are similar to Sanofi India?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Natco Pharma Limited (NATCOPHARM.NS), Strides Pharma Science Limited (STAR.NS), Sanofi Cons Healthc IND L (SANOFICONR.BO), Sun Pharma Advanced Research Company Limited (SPARC.NS).

Sanofi India Limited (SANOFI.NS) Stock

About Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio...

At a glance

Sanofi India reported revenue of 19.89 billion INR for fiscal year 2024, up 0.4% from fiscal year 2023, and net income of 4.13 billion INR. In Q2 2025 (the quarter ended June 30, 2025) revenue was 4.06 billion INR, down 12.3% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2024.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.